Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Bone Biologics Corp (OTC: BBLG).

Full DD Report for BBLG

You must become a subscriber to view this report.


Recent News from (OTC: BBLG)

Bone Biologics Completes $5.9 Million of Financing
Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, announced today the completion of $5.9 million funding; $3.9 million in equity and a $2 million credit facility. Proceeds will be used for working capital, protein devel...
Source: Business Wire
Date: July, 23 2018 08:00
Bone Biologics Completes $500,000 of Financing
Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets, announced today the completion of $500,000 funding with Orthofix Holding, Inc. The funding represents the second round of a previously announced private placement. T...
Source: Business Wire
Date: March, 29 2018 08:00
Bone Biologics Release: New Preclinical Data For Spine Fusion Demonstrates Osteopromotive Properties
Data from this pilot animal study support rhNELL-1 advancing into later-stage preclinical testing by mid-2018 rhNELL-1 program remains on track to initiate human trials in 2019 Bone Biologics Corp. (OTC QB: BBLG), a developer of orthobiologic products for the spinal fusion, trau...
Source: Business Wire
Date: December, 20 2017 08:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-07N/A26.00N/AN/A0
2018-12-06N/A26.00N/AN/A0
2018-12-05N/A26.00N/AN/A0
2018-12-04N/A26.00N/AN/A0
2018-12-03N/A26.00N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-07-1310030033.3333Cover
2018-07-052001,20016.6667Cover
2018-06-2510020050.0000Short
2018-05-21100100100.0000Short
2018-04-27502,9501.6949Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BBLG.


About Bone Biologics Corp (OTC: BBLG)

Logo for Bone Biologics Corp (OTC: BBLG)

Bone Biologics was founded to pursue regenerative medicine for bone. Bone Biologics is currently focusing its development efforts of its bone graft substitute product on bone regeneration in spinal fusion. Our proprietary platform technology, NELL , is a recombinant human protein growth factor that is essential for normal bone development.

 

Contact Information

 

 

Current Management

  • Stephen LaNeve / CEO
  • Jeffrey Frelick / COO
  • Deina Walsh / CFO
  • Bruce Stroever / Chairman
  • John Booth /
  • Jimmy Deshland /
  • Bret Hankey /

Current Share Structure

  • Market Cap: $88,232,247 - 03/15/2018
  • Authorized: 100,000,000 - 03/15/2018
  • Issue and Outstanding: 43,679,330 - 03/15/2018

 


Recent Filings from (OTC: BBLG)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: April, 03 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Amendment to a previously filed Form D
Filing Type: D/AFiling Source: edgar
Filing Date: March, 30 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: December, 15 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 11 2017
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: November, 16 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 14 2017

 

 


Daily Technical Chart for (OTC: BBLG)

Daily Technical Chart for (OTC: BBLG)


Stay tuned for daily updates and more on (OTC: BBLG)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BBLG)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BBLG is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BBLG and does not buy, sell, or trade any shares of BBLG. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/